Laxmi Dental Limited
NSE: LAXMIDENTL · Medical Equipment & Supplies · sector
₹171.87NSE close 2026-10-26
Key numbers
Market cap₹945 cr
Price₹171.87
52w high / low₹345 / ₹156
P/E30.4xSector median 20.2x
P/B3.9xSector median 2.6x
Book value₹44.3
Dividend yield–Sector median 0.24%
ROE13.7%Sector median 12.4%
ROCE13.4%Sector median 13.5%
OPM14.0%Sector median 13.8%
Debt / equity0.00xSector median 0.13x
EV/EBITDA23.0xSector median 16.4x
Interest cover27.1x
Current ratio6.21x
Sales growth 3y–Sector median +12.9%
Profit growth 3y–Sector median +4.1%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹22 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 27.1x in the last 12 months.
- Other income was 30% of net profit in the last 12 months.
- No dividend in the last 2 financial years.
- Price ₹171.87 on 2026-10-26: -50.2% from the 52-week high, +10.3% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹514.10 · low ₹168.45
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 62 | 61 | 66 | 72 | 66 | 74 | 75 |
| EBITDA | 10 | 10 | 12 | 11 | 1 | 14 | 14 |
| OPM % | 15.6% | 16.4% | 18.2% | 15.2% | 1.8% | 18.3% | 19.2% |
| Other income | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Net profit | 5 | 4 | 8 | 9 | 2 | 10 | 10 |
| EPS (₹) | 0.88 | 0.79 | 1.53 | 1.59 | 0.37 | 1.83 | 1.87 |
| Revenue YoY | +7.1% | +21.9% | +13.9% | ||||
| Profit YoY | -58.7% | +135.5% | +22.8% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY25 | FY26 | TTM |
|---|---|---|---|
| Revenue | 239 | 278 | 287 |
| EBITDA | 49 | 38 | 40 |
| Net profit | 32 | 29 | 31 |
| EPS (₹) | 6.06 | 5.53 | 5.66 |
| Revenue growth | +16.2% | – | |
| Profit growth | -8.8% | – | |
| Dividend / share (₹) | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -44.5% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 209 | 243 |
| Borrowings | 11 | 0 |
| Cash & equivalents | 109 | 22 |
| Total assets | 285 | 294 |
| Fixed assets | 41 | 59 |
| Capital work in progress | – | 0 |
| Investments | 10 | 0 |
| Receivables | 37 | 46 |
| Inventory | 19 | 22 |
| Payables | 32 | 11 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 44 | -5 |
| Cash from investing | -29 | -80 |
| Cash from financing | 111 | -18 |
| Capex | 16 | 18 |
| Free cash flow | 28 | -23 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 15.2% | 11.9% |
| ROCE % | 16.9% | 12.4% |
| Debtor days | 56 | 60 |
| Inventory days | 119 | 97 |
| Payable days | 204 | 47 |
| Cash conversion cycle (days) | -29 | 110 |
| Working capital days | 199 | 211 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 41.75% |
| FIIs | 6.58% |
| DIIs | 10.68% |
| of which Mutual funds | 9.77% |
| Public (non-institutions) | 41.00% |
| Quarter | Jan 2025 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 41.70% | 41.70% | 41.70% | 41.70% | 41.70% | 41.77% | 41.80% | 41.75% |
| Promoter group | % |
|---|---|
| Rajesh Vrajlal Khakhar | 16.93% |
| Sameer Kamlesh Merchant | 15.81% |
| Jigna Rajesh Khakhar | 7.83% |
| Kunal K Merchant | 0.92% |
| Dharmesh Bhupendra Dattani | 0.24% |
| Hasmukh Vrajlal Khakhar | 0.02% |
| Parth Rajesh Khakhar | 0.00% |
| Siddhi Rajesh Khakhar | 0.00% |
| Leelaben Vrajlal Khakhar | 0.00% |
| Sanjay Vrajlal Khakhar | 0.00% |
| Rupal Parag Bhimjiyani | 0.00% |
| Sonal A. Desai | 0.00% |
| Bhavna Bhupendra Dattani | 0.00% |
| Bhavi Sameer Merchant | 0.00% |
| Yuvraj Merchant | 0.00% |
| Public holders above 1% | % |
|---|---|
| Orbimed Asia II Mauritius Limited | 22.38% |
| ICICI Prudential Healthcare Fund | 4.41% |
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | 3.49% |
| Amrish Desai | 2.01% |
| Parag Jamnadas Bhimjiyani | 2.01% |
| Uti-healthcare Fund | 1.46% |
| HDFC Mutual Fund - HDFC Consumption Fund | 1.37% |
| Ashoka India Equity Investment Trust PLC | 1.01% |
36,680 shareholders. Pledged: – of promoter shares.
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Laboratory Business | ₹197 cr | 69.8% | ₹30 cr | 15.3% |
| Aligners Business | ₹77 cr | 27.2% | ₹14 cr | 18.8% |
| Other business | ₹9 cr | 3.1% | ₹-1 cr | -14.2% |
Documents
- Annual report FY26
- Annual report FY25
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | LAXMIDENTL |
| BSE code | 544339 |
| ISIN | INE0WO601020 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.